Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $80M
Founded date: 2020
Investors 4
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | MRL Ventur... | mrlv.com |
| - | Altitude L... | altitudels... |
| 16.06.2023 | Ono Ventur... | onoventure... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.06.2023 | Series A | $25M | UPMC Enter... |
| 26.10.2021 | Series A | $55M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 16.06.2023 | Ono Venture Investment Invests in Mozart Therapeutics. (Moz... | - | onoventure... |
| 07.06.2023 | Mozart Therapeutics Raises $25M in Expanded Series A Financi... | Mozart Therapeutics, a Seattle, WA-based developer of CD8 Treg Modulators for the treatment of autoi... | finsmes.co... |
| 29.10.2021 | Funding news: Microsoft vets land cash for new sales data sh... | Groopit CEO Tammy Savage. (Groopit Photo) Here’s our latest rundown on recent startup investment ne... | geekwire.c... |
| 27.10.2021 | Coinbase looks across the pond for inspiration | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 27.10.2021 | Coinbase looks across the pond for inspiration | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 27.10.2021 | Mozart Therapeutics Closes $55M in Series A | SEATTLE, WA, Mozart Therapeutics has secured $55 million in Series A funding led by ARCH Venture P... | vcnewsdail... |
| 26.10.2021 | Eli Lilly, Bayer, Merck join Mozart's chorus to the tune of ... | Mozart's resonance down the ages has gone beyond the musical sphere and into life sciences as a new ... | fiercebiot... |
| 26.10.2021 | Founded last year, Mozart Therapeutics lands $55M to develop... | Mozart Therapeutics CEO Katie Fanning. (Mozart Photo) A year and a few months since its founding, M... | geekwire.c... |
| 26.10.2021 | Mozart Therapeutics Launches with $55 Million Series A Finan... | - Advancing First-In-Class CD8 Treg Modulators to Restore Immune Balance SEATTLE, Oct. 26, 2021 /PR... | marketscre... |
| - | Mozart Therapeutics | “Mozart Therapeutics is developing CD8 Treg modulators for the treatment of autoimmune and inflammat... | fastfounde... |